Advertisement

Digestive Diseases and Sciences

, Volume 60, Issue 12, pp 3525–3535 | Cite as

Liver Metastasis from Colorectal Cancer in the Elderly: Is Surgery Justified?

  • Minghao Xie
  • Jinling Zhu
  • Xiaosheng He
  • Zihuan Yang
  • Xinlin Chen
  • Ping Lan
  • Lei Lian
Review

Abstract

Background

The elderly population with liver metastasis from colorectal cancer has been increasing. As the potentially curative treatment, the role of liver resection in the elderly remains undetermined.

Aims

This study provides a meta-analysis on the outcome of liver resection of colorectal liver metastasis in patients aged over 70.

Methods

PubMed, Embase, Ovid, Web of Science, and Cochrane databases from the years 2000 to 2015 were searched for eligible studies. Data on perioperative mortality, postoperative complications, and survival were collected.

Results

Twelve retrospective studies with a total of 11,285 patients (2498 elderly patients and 8787 younger patients) were identified. The elderly (>70 years old) were associated with a similar overall complication rate (30.5 vs. 28.0 %; OR 1.08; 95 % CI 0.91–1.28; p = 0.39) and a higher 30-day mortality (OR 1.92; 95 % CI 1.12–3.31; p = 0.02) after liver resection of colorectal liver metastasis (CRLM). The overall survival showed a significant difference in favor of the younger patients (HR 0.76; 95 % CI 0.65–0.89; p = 0.0007). However, with regard to disease-free survival, there was no significant difference between elderly and younger patients (HR 0.93; 95 % CI 0.82–1.06; p = 0.30).

Conclusion

Liver resection of CRLM is relatively safe in carefully selected elderly patients. Liver resection should be offered to selected elderly patients with CRLM.

Keywords

Colorectal cancer Liver metastasis Liver resection Elderly 

Notes

Acknowledgments

This study is supported by Guangdong Provincial Scientific Technology Foundation (#B2012149), National Natural Science Foundation of China for Young Investigators (#81200332), and Pearl River S&T Nova Program of Guangzhou (#2014J2200040).

Conflict of interest

None.

References

  1. 1.
    Etzioni DA, Beart RJ, Madoff RD, Ault GT. Impact of the aging population on the demand for colorectal procedures. Dis Colon Rectum. 2009;52:583–591.CrossRefPubMedGoogle Scholar
  2. 2.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.CrossRefPubMedGoogle Scholar
  3. 3.
    Su SY, Huang JY, Jian ZH, Ho CC, Lung CC, Liaw YP. Mortality of colorectal cancer in Taiwan, 1971–2010: temporal changes and age-period-cohort analysis. Int J Colorectal Dis. 2012;27:1665–1672.CrossRefPubMedGoogle Scholar
  4. 4.
    Sung JJ, Lau JY, Young GP, et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut. 2008;57:1166–1176.CrossRefPubMedGoogle Scholar
  5. 5.
    Institute, National Cancer. Surveillance, epidemiology and end results. http://seer.cancer.gov/statfacts/html/colorect.html.
  6. 6.
    Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–827.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Weiss MJ, D’Angelica MI. Patient selection for hepatic resection for metastatic colorectal cancer. J Gastrointest Oncol. 2012;3:3–10.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–321.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Pasetto LM, Stefano T, Rossi E, Paris MK, Monfardini S. Treatment of stage IV colorectal carcinoma in elderly patients. Crit Rev Oncol Hematol. 2005;54:145–155.CrossRefPubMedGoogle Scholar
  10. 10.
    Hutchins LF, Unger JM, Crowley JJ, Coltman CJ, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061–2067.CrossRefPubMedGoogle Scholar
  11. 11.
    Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ. 2000;321:531–535.CrossRefPubMedGoogle Scholar
  12. 12.
    Adam R, Frilling A, Elias D, et al. Liver resection of colorectal metastases in elderly patients. Br J Surg. 2010;97:366–376.CrossRefPubMedGoogle Scholar
  13. 13.
    Brand MI, Saclarides TJ, Dobson HD, Millikan KW. Liver resection for colorectal cancer: liver metastases in the aged. Am Surg. 2000;66:412–416.PubMedGoogle Scholar
  14. 14.
    Cannon RM, Martin RC, Callender GG, McMasters KM, Scoggins CR. Safety and efficacy of hepatectomy for colorectal metastases in the elderly. J Surg Oncol. 2011;104:804–808.CrossRefPubMedGoogle Scholar
  15. 15.
    Figueras J, Ramos E, Lopez-Ben S, et al. Surgical treatment of liver metastases from colorectal carcinoma in elderly patients. When is it worthwhile? Clin Transl Oncol. 2007;9:392–400.CrossRefPubMedGoogle Scholar
  16. 16.
    Kulik U, Framke T, Grosshennig A, et al. Liver resection of colorectal liver metastases in elderly patients. World J Surg. 2011;35:2063–2072.CrossRefPubMedGoogle Scholar
  17. 17.
    Mann CD, Neal CP, Pattenden CJ, et al. Major resection of hepatic colorectal liver metastases in elderly patients—an aggressive approach is justified. Eur J Surg Oncol. 2008;34:428–432.CrossRefPubMedGoogle Scholar
  18. 18.
    Mazzoni G, Tocchi A, Miccini M, et al. Surgical treatment of liver metastases from colorectal cancer in elderly patients. Int J Colorectal Dis. 2007;22:77–83.CrossRefPubMedGoogle Scholar
  19. 19.
    Menon KV, Al-Mukhtar A, Aldouri A, Prasad RK, Lodge PA, Toogood GJ. Outcomes after major hepatectomy in elderly patients. J Am Coll Surg. 2006;203:677–683.CrossRefPubMedGoogle Scholar
  20. 20.
    Nagano Y, Nojiri K, Matsuo K, et al. The impact of advanced age on hepatic resection of colorectal liver metastases. J Am Coll Surg. 2005;201:511–516.CrossRefPubMedGoogle Scholar
  21. 21.
    Tamandl D, Gruenberger B, Herberger B, Kaczirek K, Gruenberger T. Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients. J Surg Oncol. 2009;100:364–371.CrossRefPubMedGoogle Scholar
  22. 22.
    Nomi T, Fuks D, Kawaguchi Y, Mal F, Nakajima Y, Gayet B. Laparoscopic major hepatectomy for colorectal liver metastases in elderly patients: a single-center, case-matched study. Surg Endosc. 2014;29:1368–1375.CrossRefPubMedGoogle Scholar
  23. 23.
    Di Benedetto F, Berretta M, D’Amico G, et al. Liver resection for colorectal metastases in older adults: a paired matched analysis. J Am Geriatr Soc. 2011;59:2282–2290.CrossRefPubMedGoogle Scholar
  24. 24.
    Fong Y, Blumgart LH, Fortner JG, Brennan MF. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg. 1995;222:426–437.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Zieren HU, Muller JM, Zieren J. Resection of colorectal liver metastases in old patients. Hepatogastroenterology. 1994;41:34–37.PubMedGoogle Scholar
  26. 26.
    Golfinopoulos V, Pentheroudakis G, Pavlidis N. Treatment of colorectal cancer in the elderly: a review of the literature. Cancer Treat Rev. 2006;32:1–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Kurian AA, Wang L, Grunkemeier G, Bhayani NH, Swanstrom LL. Defining “the elderly” undergoing major gastrointestinal resections: receiver operating characteristic analysis of a large ACS-NSQIP cohort. Ann Surg. 2013;258:483–489.CrossRefPubMedGoogle Scholar
  28. 28.
    Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–2834.CrossRefPubMedGoogle Scholar
  29. 29.
    Nojiri K, Nagano Y, Tanaka K, et al. Validity of hepatic resection of colorectal liver metastases in the elderly (75 years and older). Anticancer Res. 2009;29:583–588.PubMedGoogle Scholar
  30. 30.
    Cook EJ, Welsh FK, Chandrakumaran K, John TG, Rees M. Resection of colorectal liver metastases in the elderly: does age matter? Colorectal Dis. 2012;14:1210–1216.CrossRefPubMedGoogle Scholar
  31. 31.
    U.S. Bureau of the Census. Annual estimates of the resident population for selected age groups by sex for the United States. http://www.census.gov/popest/data/national/asrh/2012/index.html; 2012. Accessed October 20, 2013.
  32. 32.
    U.S. Bureau of the Census. Life expectancy—the 2012 statistical abstract. Available at: http://www.census.gov/compendia/statab/cats/births_deaths_marriages_divorces/life_expectancy.html. Accessed October 20, 2013.
  33. 33.
    Colorectal Cancer Collaborative Group. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet. 2000;356:968–974.CrossRefGoogle Scholar
  34. 34.
    Wetle T. Age as a risk factor for inadequate treatment. JAMA. 1987;258:516.CrossRefPubMedGoogle Scholar
  35. 35.
    Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254–259.PubMedCentralCrossRefPubMedGoogle Scholar
  36. 36.
    Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109:718–726.CrossRefPubMedGoogle Scholar
  37. 37.
    Zacharias T, Jaeck D, Oussoultzoglou E, Bachellier P, Weber JC. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg. 2004;240:858–865.PubMedCentralCrossRefPubMedGoogle Scholar
  38. 38.
    Goldberg RM, Tabah-Fisch I, Bleiberg H, et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol. 2006;24:4085–4091.CrossRefPubMedGoogle Scholar
  39. 39.
    Folprecht G, Seymour MT, Saltz L, et al. Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials. J Clin Oncol. 2008;26:1443–1451.CrossRefPubMedGoogle Scholar
  40. 40.
    Van Cutsem E, Nordlinger B, Cervantes A. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol. 2010;21:v93–v97.CrossRefPubMedGoogle Scholar
  41. 41.
    Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93:850–857.CrossRefPubMedGoogle Scholar
  42. 42.
    McNicol L, Story DA, Leslie K, et al. Postoperative complications and mortality in older patients having non-cardiac surgery at three Melbourne teaching hospitals. Med J Aust. 2007;186:447–452.PubMedGoogle Scholar
  43. 43.
    Matsumata T, Taketomi A, Kawahara N, Higashi H, Shirabe K, Takenaka K. Morbidity and mortality after hepatic resection in the modern era. Hepatogastroenterology. 1995;42:456–460.PubMedGoogle Scholar
  44. 44.
    Doci R, Gennari L, Bignami P, et al. Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg. 1995;82:377–381.CrossRefPubMedGoogle Scholar
  45. 45.
    Sulpice L, Rayar M, Campillo B, et al. Advanced age remains an achilles heel for liver resections. World J Surg. 2014;38:918–926.CrossRefPubMedGoogle Scholar
  46. 46.
    Mamidanna R, Almoudaris AM, Faiz O. Is 30-day mortality an appropriate measure of risk in elderly patients undergoing elective colorectal resection? Colorectal Dis. 2012;14:1175–1182.CrossRefPubMedGoogle Scholar
  47. 47.
    Visser BC, Keegan H, Martin M, Wren SM. Death after colectomy: it’s later than we think. Arch Surg. 2009;144:1021–1027.CrossRefPubMedGoogle Scholar
  48. 48.
    Gagner M, Franco D, Vons C, Smadja C, Rossi RL, Braasch JW. Analysis of morbidity and mortality rates in right hepatectomy with the preoperative APACHE II score. Surgery. 1991;110:487–492.PubMedGoogle Scholar
  49. 49.
    Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38–46.CrossRefPubMedGoogle Scholar
  50. 50.
    Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010;210:901–908.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Colorectal SurgeryThe Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangzhouPeople’s Republic of China
  2. 2.Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor DiseasesThe Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangzhouPeople’s Republic of China
  3. 3.Guangdong Institute of Gastroenterology The Sixth Affiliated Hospital, Sun Yat-sen UniversityGuangzhouPeople’s Republic of China
  4. 4.Department of Preventive Medicine and Biostatistics, Basic Medical CollegeGuangzhou University of Chinese MedicineGuangzhouPeople’s Republic of China

Personalised recommendations